Tissue Engineering Market is valued at USD 18.54 Billion in 2022 and is expected to reach USD 52.08 Billion by 2029 with a CAGR of 15.90% over the forecast period.
Increasing clinical procedures with newer innovative developments in 3D printing are driving the growth of the tissue engineering market.
Tissue engineering is an interdisciplinary field that deals with the practice of uniting different scaffolds, cells, and biologically active molecules into functional tissues. The main aim of tissue engineering is to collect functional constructs that restore, maintain or improve damaged tissues or body organs. It combines the principles of biomaterials and cell transplantation to create substitute tissues and promote endogenous regeneration. Previously, the first tissue engineering patterns was created in the use of supportive matrices that provide associated cells with a substrate appropriate for attachment and multiplication towards the desired tissue. In the field of tissue engineering, researchers are trying to replace the injured or damaged tissues or organs with functional engineered substitutes in the body. Tissue engineering has some main functions in the areas of medicine and research which helps for tissue or organ repair such as bone repair, cartilage tissue, cardiac tissue, pancreas tissue, and vascular tissue.
The tissue engineering market is segmented on the basis of material type, application, and region. Based on material type the, tissue engineering market is segmented into Nano-fibrous material, biomimetic material, composite material, and Nano-composite material. Based upon application, the market is divided into orthopedics, musculoskeletal and spine, skin/integumentary, cancer, dental, cardiology, urology, neurology, cord blood and cell banking, and GI and gynecology.
The regions covered in this tissue engineering market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of Tissue Engineering Market is subdivided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key players of the tissue engineering market are,
The global tissue engineering market is primarily driven by the increasing need to improve clinical procedures for the repair of damaged tissues or organs and growing technological advancements of 3D bioprinting. Nowadays, tissue engineering is used extensively in clinical procedures and most of the patients have been treated with tissue engineering technologies. The global financing of tissue engineering was worth of USD 14.4 million in Q1 2019. Tissue and organ failures are becoming serious and common medical conditions for which different treatment options such as organ transplantation or surgical repair in tissue engineering are increasingly adopted by healthcare professionals. Furthermore, tissue engineering is a rapidly growing area in the ﬁeld of biomedical engineering is another factor propelling the growth of this market. . However, tissue engineering is a complex procedure that requires in-depth understanding and skilled professionals may hamper the growth of the tissue engineering market. Major advances, research, and innovations are being made in the fields of tissue engineering will have a major impact on 3D bioprinting of tissues and organs and these factors will offer lucrative opportunities for the tissue engineering market.
North America is expected to dominate the tissue engineering market due to the large healthcare infrastructure, the government’s favorable initiatives, and the presence of multiple public tissue engineering companies in this region. Around 21 companies achieved approximately USD 9 billion in sales of tissue engineering-related products in 2017. For example; Federal agencies are significantly involved in tissue science engineering that will be required in the United States and it actively sets the standards for the efficient and effective management of tissue science.
Europe is the second leading region in the tissue engineering market followed by the Asia Pacific owing to the extensive research activities are being carried out and the high emergence of tissue-engineered products (TEPs) in this region. Asia pacific is exhibited to be the fastest-growing region in the tissue engineering market due to the widespread biomedical industry, increasing geriatric population, and rising overall burden of chronic diseases and injuries.
Middle East and Africa
|2015 - 2020
|2021 - 2027
|Market Size in 2020:
|USD 10.23 Billion
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2027:
|USD 28.47 Billion
|Tables, Charts & Figures:
|Tissue Engineering Companies
|Stryker,Allergan,Medtronic,Zimmer,Baxter International,Integra LifeSciences,Organovo Holdings Inc,Cook Medical,DePuy Synthes,Acelity,Others
|By Material, By Application
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®